GSK shares dive as weaker vaccine sales unnerve investors
28 octobre 2026 | Julia Kollewe
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its (…)
Site référencé: The Guardian
2918.jpg?width=140&quality=85&auto=format&fit=max&s=0b8274bfd54de7ad73c832342d729ace, 2918.jpg?width=460&quality=85&auto=format&fit=max&s=a14734a98e59560c2ff394433f926db7, 2918.jpg?width=700&quality=85&auto=format&fit=max&s=d3765cb277c8683828af89dd31c717fb
